Shadi Darvish Shafighi

Shadi Darvish Shafighi

Auto-generated profile, based on publicly available information

Shadi Darvish Shafighi

Faculty of Mathematics, Informatics and Mechanics, University of Warsaw , Warsaw, 02-097

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 September 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
SSShadi Darvish Shafighi
Shadi Darvish Shafighi
AGAgnieszka Geras
Agnieszka Geras
BJBarbara Jurzysta
Barbara Jurzysta
ANAlireza Sahaf Naeini
Alireza Sahaf Naeini
IFIgor Filipiuk
Igor Filipiuk
ESEwa Szczurek
Ewa Szczurek
Spatial and genomic heterogeneity of tumors is the key for cancer progression, treatment, and survival. However, a technology for direct mapping the clones in the tumor tissue based on point mutations is lacking. Here, we propose Tumoroscope, the first probabilistic model that accurately infers cancer clones and their high-resolution localization by integrating pathological images, whole exome sequencing, and spatial transcriptomics data. In contrast to previous methods, Tumoroscope explicitly addresses the problem of deconvoluting the proportions of clones in spatial transcriptomics spots. Applied to a reference prostate cancer dataset and a newly generated breast cancer dataset, Tumoroscope reveals spatial patterns of clone colocalization and mutual exclusion in sub-areas of the tumor tissue. We further infer clone-specific gene expression levels and the most highly expressed genes for each clone. In summary, Tumoroscope enables an integrated study of the spatial, genomic, and phenotypic organization of tumors.

8 April 2026
Verified
Thesis
Closed access
SSShadi Darvish Shafighi
Shadi Darvish Shafighi
Modèles graphiques probabilistes pour la cartographie des clones tumoraux dans les tissus cancéreux et les cellules individuelles: L'hétérogénéité spatiale, génomique et phénotypique est essentielle pour comprendre la progression, le traitement et la survie du cancer. Cependant, l'identification des clones cancéreux et de leurs profils d'expression génique parallèlement à leur localisation dans le tissu tumoral est un défi. Cette thèse est consacrée à la modélisation complète des différents aspects de l'hétérogénéité tumorale et s'appuie sur trois projets. Dans le premier projet, nous nous sommes concentrés sur l'hétérogénéité génomique de la tumeur et avons développé un modèle probabiliste qui exploite le regroupement génomique indépendant des cellules et les rares données de séquençage de l'ARN d'une seule cellule pour cartographier les cellules à des génotypes imparfaits donnés de clones tumoraux. Dans le deuxième projet, nous avons exploré les trois aspects de l'hétérogénéité en nous concentrant principalement sur l'hétérogénéité spatiale. Nous avons développé un modèle probabiliste complexe pour déduire avec précision les clones cancéreux et leur localisation à une résolution proche de la cellule unique en intégrant des images pathologiques, le séquençage de l'exome entier et des données transcriptomiques spatiales. Dans le cadre du troisième projet, nous nous sommes concentrés sur l'hétérogénéité phénotypique. Nous avons proposé un modèle probabiliste qui combine les données de transcriptomique spatiale et de séquençage de l'exome entier pour identifier avec précision les clones cancéreux et leurs profils d'expression génique dans les tissus tumoraux. Notre approche intégrée permet de comprendre l'organisation spatiale, génomique et phénotypique des tumeurs, ce qui ouvre de nouvelles voies pour étudier les implications fonctionnelles de l'hétérogénéité des tumeurs et les origines de la résistance aux thérapies ciblées.

6 June 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
SSShadi Darvish Shafighi
Shadi Darvish Shafighi
SKSzymon M Kiełbasa
Szymon M Kiełbasa
JSJulieta Haydee Sepulveda
Julieta Haydee Sepulveda
RMRamin Monajemi
Ramin Monajemi
DCDavy Cats
Davy Cats
ESEwa Szczurek
Ewa Szczurek
Background Drawing genotype-to-phenotype maps in tumors is of paramount importance for understanding tumor heterogeneity. Assignment of single cells to their tumor clones of origin can be approached by matching the genotypes of the clones to the mutations found in RNA sequencing of the cells. The confidence of the cell-to-clone mapping can be increased by accounting for additional measurements. Follicular lymphoma, a malignancy of mature B cells that continuously acquire mutations in parallel in the exome and in B-cell receptor loci, presents a unique opportunity to align exome-derived mutations with B-cell receptor clonotypes as an independent measure for clonal evolution. Results Here, we propose CACTUS, a probabilistic model that leverages the information from an independent genomic clustering of cells and exploits the scarce single cell RNA sequencing data to map single cells to given imperfect genotypes of tumor clones. We apply CACTUS to two follicular lymphoma patient samples, integrating three measurements: whole exome sequencing, single cell RNA sequencing, and B-cell receptor sequencing. CACTUS outperforms a predecessor model by confidently assigning cells and B-cell receptor clonotypes to the tumor clones. Conclusions The integration of independent measurements increases model certainty and is the key to improving model performance in the challenging task of charting the genotype-to-phenotype maps in tumors. CACTUS opens the avenue to study the functional implications of tumor heterogeneity, and origins of resistance to targeted therapies.

2 October 2026 in Bioinformatics
Verified
Journal Article
Open access
SSShadi Shafighi
Shadi Shafighi
BJBarbara Jurzysta
Barbara Jurzysta
ESEwa Szczurek
Ewa Szczurek
Motivation: Tumors are heterogeneous mixtures of clonal subpopulations of cells that co-evolve in time and space. Apart from genetic differences, cancer clones may reside in different locations in the tumor tissue and show various transcriptional phenotypes, with specific gene expression profiles and marker genes. Computational tools that simultaneously infer genotypes and transcriptional phenotypes of clones in tumor tissues are lacking. Results: We introduce ClonalGE, a probabilistic graphical model identifying cancer clone genotypes, their gene expression profiles, and spatial mapping within tumor tissue. The model proceeds by probabilistic matching of single nucleotide variant sites in spatial transcriptomics to clone-specific variants inferred from DNA sequencing data, and by deconvoluting gene expression in spatial transcriptomics spots into contributions from individual clones. We propose a procedure that utilizes the Monte Carlo posterior samples for identification of differentially expressed genes between clones, using a Highest Density Interval plus Region of Practical Equivalence (HDI+ROPE) criterion that jointly requires credible and practically meaningful effect sizes. ClonalGE demonstrates superior performance on simulated data. Applied to a prostate cancer sample, it reveals clone-specific expression patterns and outperforms its predecessor model in accurately inferring gene expression profiles and explaining spatial transcriptomics signals. Our approach advances the functional and phenotypic characterization of clonal cell subpopulations in tumors. Availability: The implementation of ClonalGE and the data used in this study can be accessed in the following GitHub repository https://github.com/szczurek-lab/ClonalGE/. The benchmarking data alongside the intermediate results are available on Zenodo at DOI: 10.5281/zenodo.20446991.